Preparation and characterization of multiactive electrospun fibers: Poly-ε-carpolactone fibers loaded with hydroxyapatite and selected NSAIDs

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 8, 2014, Pages 2583-2589

  Karavasili, Chirstina ^a   Bouropoulos, Nikolaos ^b,c   Kontopoulou, Ioanna ^b   Smith, Ashleigh ^d   Van Der Merwe, Susanna M ^d   Rehman, Ihtesham U R ^e   Ahmad, Zeeshan ^f   Fatouros, Dimitrios G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

^d UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

bioactive and multiactive; electrospinning; hydroxyapatite; poly( caprolactone); poorly soluble drugs

Indexed keywords

BIOLOGICAL MATERIALS; BIOMATERIALS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG PRODUCTS; ELECTROSPINNING; HYDROXYAPATITE; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

BIOACTIVE AND MULTIACTIVE; BIOMATERIAL ENGINEERINGS; CAPROLACTONE; ELECTROSPUN FIBERS; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS; PHYSICO-CHEMICAL CHARACTERIZATION; POORLY SOLUBLE DRUGS; SIMULATED BODY FLUIDS;

FIBERS;

HYDROXYAPATITE; IBUPROFEN; INDOMETACIN; POLYCAPROLACTONE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYESTER;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG FORMULATION; DRUG RELEASE; ELECTROSPINNING; ENCAPSULATION; FIBER; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; CHEMISTRY; DRUG DELIVERY SYSTEM; PROCEDURES; SYNTHESIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG DELIVERY SYSTEMS; DURAPATITE; IBUPROFEN; INDOMETHACIN; MICROSCOPY, ELECTRON, SCANNING; POLYESTERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84903316805     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34931     Document Type: Article

References (33)

1. Williams GR, Chatterton NP, Nazir T, Yu DG, Zhu LM, Branford-White CJ. Electrospun nanofibers in drug delivery: recent developments and perspectives. Ther Deliv 2012; 3: 515-533.
2. Xu X, Chen X, Xu X, Lu T, Wang X, Yang L, Jing X,. BCNU-loaded PEGPLLA ultrafine fibers and their In vitro antitumor activity against Glioma C6 cells. J Control Release 2006; 114: 307-316.
3. Xie J, Wang CH,. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma In vitro. Pharm Res 2006; 23: 1817-1826.
4. Jiang H, Hu Y, Li Y, Zhao P, Zhu K, Chen W,. Afacile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. J Control Release 2005; 108: 237-243.
5. Jiang H, Hu Y, Zhao P, Li Y, Zhu K,. Modulation of protein release from biodegradable core-shell structured fibers prepared by coaxial electrospinning. J Biomed Mater Res B: Appl Biomater 2006; 79: 50-77.
6. Bolgen N, Vargel I, Korkusuz P, Menceloglu YZ, Piskin E,. In vivo performance of antibiotic embedded electrospun PCL membranes for prevention of abdominal adhesions. J Biomed Mater Res B: Appl Biomater 200; 81: 530-543.
7. Huang ZM, He CL, Yang A, Zhang Y, Han XJ, Yin J, Wu Q,. Encapsulating drugs in biodegradable ultrafine fibers through co-axial electrospinning. J Biomed Mater Res A 2006; 77: 169-179.
8. Kim K, Luu YK, Chang C, Fang D, Hsiao BS, Chu B, Hadjiargyrou M,. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-coglycolide)-based electrospun nanofibrous scaffolds. J Control Release 2004; 98: 47-56.
9. Joschek S, Nies B, Krotz R, Göferich A,. Chemical and physicochemical characterization of porous hydroxyapatite ceramics made of natural bone. Biomaterials 2000; 21: 1645-1658.
10. Gan Z, Fung JT, Jing X, Wu C, Kuliche WK,. A novel laser light-scattering study of enzymatic biodegradation of poly(ε-caprolactone) nanoparticles. Polymer 1999; 40: 1961-1967.
11. Jain A, Jain A, Gulbake A, Shilpi S, Hurkat P, Jain SK,. Crit Rev Ther Drug Carrier Syst 2013; 30: 293-329.
12. Feng S, Duan X, Lo PK, Liu S, Liu X, Chen H, Wang Q,. Expansion of breast cancer stem cells with fibrous scaffolds. IntegrBiol (Camb) 2013; 5: 768-777.
13. Manoochehr R, Zeeshan A, Richard D, Wickam A, Edirisinghe M,. Direct writing of polycaprolactone polymer for potential biomedical engineering applications. Adv Eng Mater 2011; 13: B296-B305.
14. Kim Mi-Jin, Koh, Young-Hag,. Synthesis of aligned porous poly(epsilon-caprolactone) (PCL)/hydroxyapatite (HA) composite microspheres. Mater Sci Eng C: Mater Biol Appl 2013; 33: 2266-2272.
15. Liu X, Mou Y, Wu S, Man HC,. Synthesis of silver-incorporated hydroxyapatite nanocomposites for antimicrobial implant coatings. Appl Surf Sci 2013; 273: 748-757.
16. Verreck G, Chun I, Peeters J, Rosenblatt J, Brewster ME,. Preparation and characterization of nanofibers containing amorphousdrug dispersions generated by electrostatic spinning. Pharm Res 2003; 20: 810-817.
17. Verreck G, Chun I, Peeters J, Rosenblatt J, DijckAV, Mensch J, Noppe M, Brewster ME,. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble nonbiodegradable polymer. J Control Release 2003; 92: 349-360.
18. Liu H, Venkatraman SS., Effect of polymer type on the dynamics of phase inversion and drug release in injectable in situ gelling systems. J Biomater Sci Polym Ed 2012; 23: 251-266.
19. Steele TW, Huang CL, Widjaja E, Boey FY, Loo JS, Venkatraman SS,. The effect of polyethyleneglycol structure on paclitaxel drugrelease and mechanical properties of PLGA thin films. Acta Biomater 2011; 5: 1973-1983.
20. Otsuka M, Matsuda Y, Kokubo T, Yoshihara S, Nakamura T, Yamamuro T,. A novel skeletal drug delivery system using self-setting bioactive glass bone cement. III: the In vitro drug release from bone cement containing indomethacin and its physicochemical properties. J Control Release 1994; 31: 111-119.
21. Arcos D, Cabanas MV, Ragel CV, Vallet-Regí M, San Román J,. Ibuprofen release from hydrophilic ceramic-polymer composites. Biomaterials 1997; 18: 1235-1242.
22. Ladrõn, de Guevara-Fernández S, Ragel CV, Vallet-Regí M,. Bioactive glass-polymer materials for controlled release of ibuprofen. Biomaterials 2003; 2: 4037-4043.
23. Verma D, Katti K, Katti D,. Bioactivity in in situ hydroxyapatite- polycaprolactone composites. J Biomed Mater Res A 2006; 78: 772-780.
24. Ahmad Z, Manoochehr R, Edirisinghe M,. Electrohydrodynamic direct writing of biomedical polymers and composites. 2010; 295: 315-319.
25. Casper CL, Yang W, Farach-Carson MC, Rabolt JF,. Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding. Biomacromolecules 2007; 8: 1116-1123.
26. Jiang S, Ji X, An L, Jiang B,. Crystallization behavior of PCL in hybrid confined environment. Polymer 2001; 42: 3901-3907.
27. Ramukutty S, Ramachandran E,. Growth, spectral and thermal studies of ibuprofen crystals. Cryst Res Techn 2012; 47: 31-38.
28. Zhang GC, Lin HL, Lin SY,. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process. J Pharm Biomed Anal 2012; 66: 162-169.
29. G. Penel, G, Leroy, G, Rey, C, Sombret, B, Huvenne, J, Bres, E,. Infrared and Raman microspectrometry study of fluor-fluor-hydroxy and hydroxy-apatite powders. J Mater Sci: Mater Med 1997; 8: 271-276.
30. Elzubair A, Elias CN, Suarez JC, Lopes HP, Vieira MV,. The physical characterization of a thermoplastic polymer for endodontic obturation. J Dent 2006; 34: 784-789.
31. Xiao J, Zhu Y, Liu Y, Zeng Y, Xu F,. An asymmetric coatingcomposed of gelatin and hydroxyapatite for the delivery of water insoluble drug. J Mater Sci Mater Med 2009; 20: 889-896.
32. Miao Y-E, Zhu H, Chen D, Wang R, Tjiu WW, Liu T,. Electrospun fibers of layered double hydroxide/biopolymer nanocomposites as effective drug delivery systems. Mater Chem Phys 2012; 134: 623-630.
33. Wu M, Kleiner L, Tang FW, Hossainy S, Davies MC, Roberts CJ,. Nanoscale mechanical measurement determination of the glass transition temperature of poly(lactic acid)/everolimus coated stents in air and dissolution media. Eur J Pharm Sci 2009; 36: 493-501.